anti ifnb1 Search Results


99
Thermo Fisher gene exp cxcl10 hs00171042 m1
Gene Exp Cxcl10 Hs00171042 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp cxcl10 hs00171042 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp cxcl10 hs00171042 m1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

93
R&D Systems polyclonal anti human ifn beta antibodies
Polyclonal Anti Human Ifn Beta Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal anti human ifn beta antibodies/product/R&D Systems
Average 93 stars, based on 1 article reviews
polyclonal anti human ifn beta antibodies - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rat anti-mouse ifnb1 mab sc-57201
Rat Anti Mouse Ifnb1 Mab Sc 57201, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti-mouse ifnb1 mab sc-57201/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rat anti-mouse ifnb1 mab sc-57201 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Danaher Inc ifnb1
Primer information for RT-qPCR
Ifnb1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifnb1/product/Danaher Inc
Average 86 stars, based on 1 article reviews
ifnb1 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
PBL Assay antibodies ifnb-fitc (mmhb-3)
Primer information for RT-qPCR
Antibodies Ifnb Fitc (Mmhb 3), supplied by PBL Assay, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies ifnb-fitc (mmhb-3)/product/PBL Assay
Average 90 stars, based on 1 article reviews
antibodies ifnb-fitc (mmhb-3) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology goat anti-ifn-beta
Expressions of DRD1 and <t>IFN-beta</t> receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)
Goat Anti Ifn Beta, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti-ifn-beta/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
goat anti-ifn-beta - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PBL Assay human ifn beta
Expressions of DRD1 and <t>IFN-beta</t> receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)
Human Ifn Beta, supplied by PBL Assay, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ifn beta/product/PBL Assay
Average 90 stars, based on 1 article reviews
human ifn beta - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biogen Inc protein a purified igg fraction of rabbit anti-ifn-beta-1a polyclonal antibodies
Expressions of DRD1 and <t>IFN-beta</t> receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)
Protein A Purified Igg Fraction Of Rabbit Anti Ifn Beta 1a Polyclonal Antibodies, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein a purified igg fraction of rabbit anti-ifn-beta-1a polyclonal antibodies/product/Biogen Inc
Average 90 stars, based on 1 article reviews
protein a purified igg fraction of rabbit anti-ifn-beta-1a polyclonal antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PBL Assay antibody anti-ifnb rabbit polyclonal

Antibody Anti Ifnb Rabbit Polyclonal, supplied by PBL Assay, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody anti-ifnb rabbit polyclonal/product/PBL Assay
Average 90 stars, based on 1 article reviews
antibody anti-ifnb rabbit polyclonal - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology rat anti mouse ifnb1 mab

Rat Anti Mouse Ifnb1 Mab, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti mouse ifnb1 mab/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
rat anti mouse ifnb1 mab - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit anti-ifn-beta receptor
Expressions of DRD1 and <t>IFN-beta</t> receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)
Rabbit Anti Ifn Beta Receptor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-ifn-beta receptor/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-ifn-beta receptor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TATAA Biocenter AB tataa-sequence
(A and B), Nucleosome occupancy at an enhancer 10 kb upstream of the TSS of IL12B in BMDMs was analyzed before induction (blue bars and lines), and after 1.5 h (yellow), 3 h (orange), 5 h (light red) and 10 h (dark red) of growth of cells in the presence of 1 μg/ml LPS, using the assay described in with modifications detailed in the . In brief, occupancy was measured by determining the sensitivity of cross-linked chromatin to a wide range of MNase. Digestion data for each genomic location analyzed by qRT-PCR with specific primer pairs was fitted to two-state exponential decay functions and the percentage of DNA in the population of cells found to be protected against MNase by binding of a nucleosome is indicated on the y-axis. In panel (A) each overlapping colored bar represents the length of the amplicon measured. The minimal enhancer that was shown by Zhou et al. to contain the LPS-inducible DNaseI hypersensitive site HSS1 as well as consensus-sites for Oct1/2 and C/EBPβ is indicated by the black bar . Consensus-sites for PU.1, NFκB, AP1 and IRF identified using ConSite are indicated. In panel (B) nucleosome occupancy at the midpoint of each amplicon measured by the experiment performed in panel (A) is indicated by a dot, with error bars showing the SEM of at least two independent measurements (10 h was measured only once). (C and D), BMDMs were induced as described in (A) and nucleosome occupancy in a region surrounding the TSS of IL12B was determined. The data is displayed as in panels (A) and (B) respectively. The black bar below the data in (C) indicates the TSS and the light blue bars indicate putative TATA-boxes predicted by ConSite. (E), Expression of IL12B, <t>IFNB1</t> and IL1A in response to LPS. mRNA from BMDMs induced with LPS as in panel A as well as from splenic B-cells was isolated as described in the , reverse transcribed and cDNA quantified by qRT-PCR. Data was normalized to a location in the ORF of the constitutively expressed RPL4 gene. The SEM of at least two independent measurements is indicated (10 h timepoint was measured only once).
Tataa Sequence, supplied by TATAA Biocenter AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tataa-sequence/product/TATAA Biocenter AB
Average 90 stars, based on 1 article reviews
tataa-sequence - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Primer information for RT-qPCR

Journal: American Journal of Translational Research

Article Title: LncRNA AL645608.3 mediates malignant progression of acute myeloid leukemia

doi:

Figure Lengend Snippet: Primer information for RT-qPCR

Article Snippet: The transferred membranes were blocked for 1 h. After discarding the sealing liquid, the diluted primary antibodies against IRF6 (#sc-37704; 1:500; Santa, Texas, USA), CBL (#25818-1-AP; 1:1000; Proteintech, Wuhan, China), IFNB1 (#ab275880; 1:500; Abcam, Massachusetts, USA), and GAPDH (#ab181602; 1:10000; Abcam) were added and incubated overnight at 4°C.

Techniques: Sequencing

Effects of AL645608.3 on the mRNA expression of IRF6, CBL and IFNB1 in AML cells. A-C. The mRNA expression of IRF6, CBL and IFNB1 in THP-1 cells infected with sh-AL645608.3 lentiviruses. D-F. The mRNA expression of IRF6, CBL and IFNB1 in AML-193 cells infected with AL645608.3 overexpression lentiviruses. ns, P>0.05; ****P<0.0001.

Journal: American Journal of Translational Research

Article Title: LncRNA AL645608.3 mediates malignant progression of acute myeloid leukemia

doi:

Figure Lengend Snippet: Effects of AL645608.3 on the mRNA expression of IRF6, CBL and IFNB1 in AML cells. A-C. The mRNA expression of IRF6, CBL and IFNB1 in THP-1 cells infected with sh-AL645608.3 lentiviruses. D-F. The mRNA expression of IRF6, CBL and IFNB1 in AML-193 cells infected with AL645608.3 overexpression lentiviruses. ns, P>0.05; ****P<0.0001.

Article Snippet: The transferred membranes were blocked for 1 h. After discarding the sealing liquid, the diluted primary antibodies against IRF6 (#sc-37704; 1:500; Santa, Texas, USA), CBL (#25818-1-AP; 1:1000; Proteintech, Wuhan, China), IFNB1 (#ab275880; 1:500; Abcam, Massachusetts, USA), and GAPDH (#ab181602; 1:10000; Abcam) were added and incubated overnight at 4°C.

Techniques: Expressing, Infection, Over Expression

Effects of AL645608.3 on the protein expression of IRF6, CBL and IFNB1 in AML cells. A. Representative western blot images for IRF6, CBL and IFNB1 in THP-1 cells with sh-AL645608.3 lentiviruses infection and in AML-193 cells with AL645608.3 overexpression lentiviruses infection. B-D. Western blot for the detection of protein levels of IRF6, CBL and IFNB1 in THP-1 cells infected with sh-AL645608.3 lentiviruses. E-G. Western blot for the detection of protein levels of IRF6, CBL and IFNB1 in AML-193 cells infected with AL645608.3 overexpression lentiviruses. ns, P>0.05; **P<0.01; ***P<0.001; ****P<0.0001.

Journal: American Journal of Translational Research

Article Title: LncRNA AL645608.3 mediates malignant progression of acute myeloid leukemia

doi:

Figure Lengend Snippet: Effects of AL645608.3 on the protein expression of IRF6, CBL and IFNB1 in AML cells. A. Representative western blot images for IRF6, CBL and IFNB1 in THP-1 cells with sh-AL645608.3 lentiviruses infection and in AML-193 cells with AL645608.3 overexpression lentiviruses infection. B-D. Western blot for the detection of protein levels of IRF6, CBL and IFNB1 in THP-1 cells infected with sh-AL645608.3 lentiviruses. E-G. Western blot for the detection of protein levels of IRF6, CBL and IFNB1 in AML-193 cells infected with AL645608.3 overexpression lentiviruses. ns, P>0.05; **P<0.01; ***P<0.001; ****P<0.0001.

Article Snippet: The transferred membranes were blocked for 1 h. After discarding the sealing liquid, the diluted primary antibodies against IRF6 (#sc-37704; 1:500; Santa, Texas, USA), CBL (#25818-1-AP; 1:1000; Proteintech, Wuhan, China), IFNB1 (#ab275880; 1:500; Abcam, Massachusetts, USA), and GAPDH (#ab181602; 1:10000; Abcam) were added and incubated overnight at 4°C.

Techniques: Expressing, Western Blot, Infection, Over Expression

Expressions of DRD1 and IFN-beta receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Expressions of DRD1 and IFN-beta receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)

Article Snippet: After blocking with 5% nonfat milk for 1.5 h, the membranes were incubated overnight at 4 °C with the primary antibodies: rabbit anti-DRD1 (1:1000, Abcam), goat anti-IFN-beta (1:300, Santa Cruz), rabbit anti-IFN-beta receptor (1:500, Santa Cruz), rabbit anti-STAT1(1:2000, Cell Signaling), goat anti-p-STAT1 (1:500, Santa Cruz), rabbit anti-NLRP3 (1:1000, MyBioSource), rabbit anti-caspase1 (1:1000, NOVUS Biologicals), rabbit anti-IL-1beta (1:2000, Cell Signaling), and rabbit anti-β-actin (1:2000, Santa Cruz). β-actin served as the loading control.

Techniques:

Expressions of DRD1 and IFN-beta in the ipsilateral hemispheres after intracerebral hemorrhage (ICH). a Representative photographs of DRD1 and IFN-beta in western blotting. b Bar graphs of quantitative analysis of DRD1 and IFN-beta expressions from the ipsilateral hemisphere after ICH. DRD1 and IFN-beta expressions increased, * p < 0.05, ** p < 0.01 versus sham; DRD1 and IFN-beta expressions decreased, # p < 0.05, ## p < 0.01 versus sham

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Expressions of DRD1 and IFN-beta in the ipsilateral hemispheres after intracerebral hemorrhage (ICH). a Representative photographs of DRD1 and IFN-beta in western blotting. b Bar graphs of quantitative analysis of DRD1 and IFN-beta expressions from the ipsilateral hemisphere after ICH. DRD1 and IFN-beta expressions increased, * p < 0.05, ** p < 0.01 versus sham; DRD1 and IFN-beta expressions decreased, # p < 0.05, ## p < 0.01 versus sham

Article Snippet: After blocking with 5% nonfat milk for 1.5 h, the membranes were incubated overnight at 4 °C with the primary antibodies: rabbit anti-DRD1 (1:1000, Abcam), goat anti-IFN-beta (1:300, Santa Cruz), rabbit anti-IFN-beta receptor (1:500, Santa Cruz), rabbit anti-STAT1(1:2000, Cell Signaling), goat anti-p-STAT1 (1:500, Santa Cruz), rabbit anti-NLRP3 (1:1000, MyBioSource), rabbit anti-caspase1 (1:1000, NOVUS Biologicals), rabbit anti-IL-1beta (1:2000, Cell Signaling), and rabbit anti-β-actin (1:2000, Santa Cruz). β-actin served as the loading control.

Techniques: Western Blot

Effects of A68930 on the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Effects of A68930 on the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle

Article Snippet: After blocking with 5% nonfat milk for 1.5 h, the membranes were incubated overnight at 4 °C with the primary antibodies: rabbit anti-DRD1 (1:1000, Abcam), goat anti-IFN-beta (1:300, Santa Cruz), rabbit anti-IFN-beta receptor (1:500, Santa Cruz), rabbit anti-STAT1(1:2000, Cell Signaling), goat anti-p-STAT1 (1:500, Santa Cruz), rabbit anti-NLRP3 (1:1000, MyBioSource), rabbit anti-caspase1 (1:1000, NOVUS Biologicals), rabbit anti-IL-1beta (1:2000, Cell Signaling), and rabbit anti-β-actin (1:2000, Santa Cruz). β-actin served as the loading control.

Techniques: Western Blot

DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on neurological outcome and brain water content after ICH. Garcia test score ( a ), left forelimb placement ( b ), and brain water content ( c ) at 24 h after ICH. ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05 versus scramble siRNA group

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on neurological outcome and brain water content after ICH. Garcia test score ( a ), left forelimb placement ( b ), and brain water content ( c ) at 24 h after ICH. ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05 versus scramble siRNA group

Article Snippet: After blocking with 5% nonfat milk for 1.5 h, the membranes were incubated overnight at 4 °C with the primary antibodies: rabbit anti-DRD1 (1:1000, Abcam), goat anti-IFN-beta (1:300, Santa Cruz), rabbit anti-IFN-beta receptor (1:500, Santa Cruz), rabbit anti-STAT1(1:2000, Cell Signaling), goat anti-p-STAT1 (1:500, Santa Cruz), rabbit anti-NLRP3 (1:1000, MyBioSource), rabbit anti-caspase1 (1:1000, NOVUS Biologicals), rabbit anti-IL-1beta (1:2000, Cell Signaling), and rabbit anti-β-actin (1:2000, Santa Cruz). β-actin served as the loading control.

Techniques:

DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on DRD1/IFN-beta/STAT1/NLRP3 signaling pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05, && p < 0.01 versus scramble siRNA group

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on DRD1/IFN-beta/STAT1/NLRP3 signaling pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05, && p < 0.01 versus scramble siRNA group

Article Snippet: After blocking with 5% nonfat milk for 1.5 h, the membranes were incubated overnight at 4 °C with the primary antibodies: rabbit anti-DRD1 (1:1000, Abcam), goat anti-IFN-beta (1:300, Santa Cruz), rabbit anti-IFN-beta receptor (1:500, Santa Cruz), rabbit anti-STAT1(1:2000, Cell Signaling), goat anti-p-STAT1 (1:500, Santa Cruz), rabbit anti-NLRP3 (1:1000, MyBioSource), rabbit anti-caspase1 (1:1000, NOVUS Biologicals), rabbit anti-IL-1beta (1:2000, Cell Signaling), and rabbit anti-β-actin (1:2000, Santa Cruz). β-actin served as the loading control.

Techniques: Western Blot

Journal: eLife

Article Title: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis

doi: 10.7554/eLife.51071

Figure Lengend Snippet:

Article Snippet: Antibody , anti-IFNB Rabbit polyclonal , PBL Assay Science , 32400–1 , (1:250 neutralizing).

Techniques: Sequencing, Recombinant

Expressions of DRD1 and IFN-beta receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Expressions of DRD1 and IFN-beta receptor in microglia. a Co-localization of DRD1 with Iba 1 and of IFN-beta receptor with Iba 1 was observed in the perihematoma brain tissue (showing with black triangle) at 24 h after ICH. b Representative photographs of co-localization of DRD1 with Iba 1 (bar = 50 μm). c Representative photographs of co-localization of IFN-beta receptor with Iba 1 (bar = 50 μm)

Article Snippet: A series of coronal brain sections (10 μm thick) were blocked in 5% bovine serum albumin for 2 h at room temperature and then were incubated with rabbit anti-DRD1 (1:200, Abcam), rabbit anti-IFN-beta receptor (1:50, Santa Cruz), goat anti-ionized calcium-binding adapter molecule 1 (Iba 1, 1:200, Abcam), and rabbit anti-MPO (1:100, Abcam) at 4 °C overnight.

Techniques:

Expressions of DRD1 and IFN-beta in the ipsilateral hemispheres after intracerebral hemorrhage (ICH). a Representative photographs of DRD1 and IFN-beta in western blotting. b Bar graphs of quantitative analysis of DRD1 and IFN-beta expressions from the ipsilateral hemisphere after ICH. DRD1 and IFN-beta expressions increased, * p < 0.05, ** p < 0.01 versus sham; DRD1 and IFN-beta expressions decreased, # p < 0.05, ## p < 0.01 versus sham

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Expressions of DRD1 and IFN-beta in the ipsilateral hemispheres after intracerebral hemorrhage (ICH). a Representative photographs of DRD1 and IFN-beta in western blotting. b Bar graphs of quantitative analysis of DRD1 and IFN-beta expressions from the ipsilateral hemisphere after ICH. DRD1 and IFN-beta expressions increased, * p < 0.05, ** p < 0.01 versus sham; DRD1 and IFN-beta expressions decreased, # p < 0.05, ## p < 0.01 versus sham

Article Snippet: A series of coronal brain sections (10 μm thick) were blocked in 5% bovine serum albumin for 2 h at room temperature and then were incubated with rabbit anti-DRD1 (1:200, Abcam), rabbit anti-IFN-beta receptor (1:50, Santa Cruz), goat anti-ionized calcium-binding adapter molecule 1 (Iba 1, 1:200, Abcam), and rabbit anti-MPO (1:100, Abcam) at 4 °C overnight.

Techniques: Western Blot

Effects of A68930 on the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: Effects of A68930 on the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle

Article Snippet: A series of coronal brain sections (10 μm thick) were blocked in 5% bovine serum albumin for 2 h at room temperature and then were incubated with rabbit anti-DRD1 (1:200, Abcam), rabbit anti-IFN-beta receptor (1:50, Santa Cruz), goat anti-ionized calcium-binding adapter molecule 1 (Iba 1, 1:200, Abcam), and rabbit anti-MPO (1:100, Abcam) at 4 °C overnight.

Techniques: Western Blot

DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on neurological outcome and brain water content after ICH. Garcia test score ( a ), left forelimb placement ( b ), and brain water content ( c ) at 24 h after ICH. ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05 versus scramble siRNA group

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on neurological outcome and brain water content after ICH. Garcia test score ( a ), left forelimb placement ( b ), and brain water content ( c ) at 24 h after ICH. ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05 versus scramble siRNA group

Article Snippet: A series of coronal brain sections (10 μm thick) were blocked in 5% bovine serum albumin for 2 h at room temperature and then were incubated with rabbit anti-DRD1 (1:200, Abcam), rabbit anti-IFN-beta receptor (1:50, Santa Cruz), goat anti-ionized calcium-binding adapter molecule 1 (Iba 1, 1:200, Abcam), and rabbit anti-MPO (1:100, Abcam) at 4 °C overnight.

Techniques:

DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on DRD1/IFN-beta/STAT1/NLRP3 signaling pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05, && p < 0.01 versus scramble siRNA group

Journal: Journal of Neuroinflammation

Article Title: Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

doi: 10.1186/s12974-017-1039-7

Figure Lengend Snippet: DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on DRD1/IFN-beta/STAT1/NLRP3 signaling pathway after ICH. a Representative photographs of the expressions of proteins in DRD1/IFN-beta/STAT1/NLRP3 pathway in western blotting. b and c Bar graphs of quantitative analysis of DRD1, IFN-beta, IFN-beta receptor, p-STAT1, NLRP3, pro-caspase1, caspase1, pro-IL-1beta, and IL-1beta, respectively. * p < 0.05, ** p < 0.01 versus sham; # p < 0.05, ## p < 0.01 versus vehicle; $ p < 0.05, $$ p < 0.01 versus A68930 group; & p < 0.05, && p < 0.01 versus scramble siRNA group

Article Snippet: A series of coronal brain sections (10 μm thick) were blocked in 5% bovine serum albumin for 2 h at room temperature and then were incubated with rabbit anti-DRD1 (1:200, Abcam), rabbit anti-IFN-beta receptor (1:50, Santa Cruz), goat anti-ionized calcium-binding adapter molecule 1 (Iba 1, 1:200, Abcam), and rabbit anti-MPO (1:100, Abcam) at 4 °C overnight.

Techniques: Western Blot

(A and B), Nucleosome occupancy at an enhancer 10 kb upstream of the TSS of IL12B in BMDMs was analyzed before induction (blue bars and lines), and after 1.5 h (yellow), 3 h (orange), 5 h (light red) and 10 h (dark red) of growth of cells in the presence of 1 μg/ml LPS, using the assay described in with modifications detailed in the . In brief, occupancy was measured by determining the sensitivity of cross-linked chromatin to a wide range of MNase. Digestion data for each genomic location analyzed by qRT-PCR with specific primer pairs was fitted to two-state exponential decay functions and the percentage of DNA in the population of cells found to be protected against MNase by binding of a nucleosome is indicated on the y-axis. In panel (A) each overlapping colored bar represents the length of the amplicon measured. The minimal enhancer that was shown by Zhou et al. to contain the LPS-inducible DNaseI hypersensitive site HSS1 as well as consensus-sites for Oct1/2 and C/EBPβ is indicated by the black bar . Consensus-sites for PU.1, NFκB, AP1 and IRF identified using ConSite are indicated. In panel (B) nucleosome occupancy at the midpoint of each amplicon measured by the experiment performed in panel (A) is indicated by a dot, with error bars showing the SEM of at least two independent measurements (10 h was measured only once). (C and D), BMDMs were induced as described in (A) and nucleosome occupancy in a region surrounding the TSS of IL12B was determined. The data is displayed as in panels (A) and (B) respectively. The black bar below the data in (C) indicates the TSS and the light blue bars indicate putative TATA-boxes predicted by ConSite. (E), Expression of IL12B, IFNB1 and IL1A in response to LPS. mRNA from BMDMs induced with LPS as in panel A as well as from splenic B-cells was isolated as described in the , reverse transcribed and cDNA quantified by qRT-PCR. Data was normalized to a location in the ORF of the constitutively expressed RPL4 gene. The SEM of at least two independent measurements is indicated (10 h timepoint was measured only once).

Journal: PLoS ONE

Article Title: Nucleosomes Are Stably Evicted from Enhancers but Not Promoters upon Induction of Certain Pro-Inflammatory Genes in Mouse Macrophages

doi: 10.1371/journal.pone.0093971

Figure Lengend Snippet: (A and B), Nucleosome occupancy at an enhancer 10 kb upstream of the TSS of IL12B in BMDMs was analyzed before induction (blue bars and lines), and after 1.5 h (yellow), 3 h (orange), 5 h (light red) and 10 h (dark red) of growth of cells in the presence of 1 μg/ml LPS, using the assay described in with modifications detailed in the . In brief, occupancy was measured by determining the sensitivity of cross-linked chromatin to a wide range of MNase. Digestion data for each genomic location analyzed by qRT-PCR with specific primer pairs was fitted to two-state exponential decay functions and the percentage of DNA in the population of cells found to be protected against MNase by binding of a nucleosome is indicated on the y-axis. In panel (A) each overlapping colored bar represents the length of the amplicon measured. The minimal enhancer that was shown by Zhou et al. to contain the LPS-inducible DNaseI hypersensitive site HSS1 as well as consensus-sites for Oct1/2 and C/EBPβ is indicated by the black bar . Consensus-sites for PU.1, NFκB, AP1 and IRF identified using ConSite are indicated. In panel (B) nucleosome occupancy at the midpoint of each amplicon measured by the experiment performed in panel (A) is indicated by a dot, with error bars showing the SEM of at least two independent measurements (10 h was measured only once). (C and D), BMDMs were induced as described in (A) and nucleosome occupancy in a region surrounding the TSS of IL12B was determined. The data is displayed as in panels (A) and (B) respectively. The black bar below the data in (C) indicates the TSS and the light blue bars indicate putative TATA-boxes predicted by ConSite. (E), Expression of IL12B, IFNB1 and IL1A in response to LPS. mRNA from BMDMs induced with LPS as in panel A as well as from splenic B-cells was isolated as described in the , reverse transcribed and cDNA quantified by qRT-PCR. Data was normalized to a location in the ORF of the constitutively expressed RPL4 gene. The SEM of at least two independent measurements is indicated (10 h timepoint was measured only once).

Article Snippet: In contrast to our findings at the IL1A and IL12B promoters we found that the TATAA-sequence in the IFNB1 promoter was cleared of nucleosomes upon induction in primary mouse macrophages as had been described for the IFNB1 promoter in human cells ( ) .

Techniques: Quantitative RT-PCR, Binding Assay, Amplification, Expressing, Isolation, Reverse Transcription

(A and B), Nucleosome occupancy was determined in BMDMs before induction (blue bars and lines), and upon induction with 1 μg/ml LPS for 1.5 h with (green) or without (yellow) pretreatment of cells with 1 μM TPG for 1 h. The minimal enhancer region (black bar) and binding sites for XBP, AP1, IRF3 and NFκB identified by are shown in (A). ConSite predicted binding sites for PU.1 and C/EBP are indicated. (C and D), Nucleosome occupancy at the proximal enhancer and promoter of IFNB1 was determined as in panel A and analyzed in a region encompassing the proximal enhancer that is conserved in humans and has been shown to form an enhanceosome upon viral stimulation of HeLa cells , as well as in the 5′ region of the IFNB1 ORF. Conserved binding sites for NFκB, ATF, AP1 and IRF3/7 identified by are indicated. ConSite-predicted consensus sites for PU.1 and C/EBP are also shown. E , Expression of IFNB1 upon stimulation with different inducers. BMDMs were induced for 3 h (dark blue) or 16 h (light blue) with 1 μg/ml of LPS, or 1 μg/ml of ISD, 1 μg/ml p(I:C), or 1 μg/ml p(dA:dT) added either alone or together with LPS as indicated. Where indicated cells were pre-treated with the ER-stress inducer TPG for 1 h prior to LPS induction. mRNA was isolated and quantified as described in the . Data was normalized to the ORF of RPL4.

Journal: PLoS ONE

Article Title: Nucleosomes Are Stably Evicted from Enhancers but Not Promoters upon Induction of Certain Pro-Inflammatory Genes in Mouse Macrophages

doi: 10.1371/journal.pone.0093971

Figure Lengend Snippet: (A and B), Nucleosome occupancy was determined in BMDMs before induction (blue bars and lines), and upon induction with 1 μg/ml LPS for 1.5 h with (green) or without (yellow) pretreatment of cells with 1 μM TPG for 1 h. The minimal enhancer region (black bar) and binding sites for XBP, AP1, IRF3 and NFκB identified by are shown in (A). ConSite predicted binding sites for PU.1 and C/EBP are indicated. (C and D), Nucleosome occupancy at the proximal enhancer and promoter of IFNB1 was determined as in panel A and analyzed in a region encompassing the proximal enhancer that is conserved in humans and has been shown to form an enhanceosome upon viral stimulation of HeLa cells , as well as in the 5′ region of the IFNB1 ORF. Conserved binding sites for NFκB, ATF, AP1 and IRF3/7 identified by are indicated. ConSite-predicted consensus sites for PU.1 and C/EBP are also shown. E , Expression of IFNB1 upon stimulation with different inducers. BMDMs were induced for 3 h (dark blue) or 16 h (light blue) with 1 μg/ml of LPS, or 1 μg/ml of ISD, 1 μg/ml p(I:C), or 1 μg/ml p(dA:dT) added either alone or together with LPS as indicated. Where indicated cells were pre-treated with the ER-stress inducer TPG for 1 h prior to LPS induction. mRNA was isolated and quantified as described in the . Data was normalized to the ORF of RPL4.

Article Snippet: In contrast to our findings at the IL1A and IL12B promoters we found that the TATAA-sequence in the IFNB1 promoter was cleared of nucleosomes upon induction in primary mouse macrophages as had been described for the IFNB1 promoter in human cells ( ) .

Techniques: Binding Assay, Expressing, Isolation